Clinical Trials Browser

Lymphadenopathy × Gastrointestinal × 1 year × Clear all

Lymphadenopathy, Pancreatic Neoplasms, Cholangiocarcinoma

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Clinical Trials

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis